Yabao Pharmaceutical Group Co., Ltd. was founded in 1978 and was listed on the A-share market of the Shanghai Stock Exchange in 2002. The company operates 8 manufacturing bases and 3 R&D centers, with multiple production lines certified by FDA, EMA, PMDA. Yabao adheres to a clinical needs-oriented approach, guided by internationalization and driven by talent and technology. It maintains a strategic focus on pediatrics while building a comprehensive portfolio across innovative drugs, high-end generics, traditional Chinese medicines, and healthcare products. The company holds over 1,000 intellectual property assets, including authorized patents and registered trademarks.